Scotia's hopes for magic bullet
The Investment Column
Wednesday 11 September 1996
Yesterday, the group was claiming that its pancreatic cancer drug, codenamed EF13, would soon outshine even Marimastat, the British Biotech anti-cancer treatment that set the sector alight last November. David Horrobin, the driving force behind Scotia, suggested EF13 could be cleared for sale in under two years and might cover a wider range of cancers. But those claims pale beside the qualities attributed to Foscan, its "magic bullet" drug which destroys cancerous cells in association with lasers. Mr Horrobin believes this could be "possibly one of the most exciting drugs, not just for Scotia but for the whole pharmaceutical industry over the next few years".
Even so, the City will remain sceptical about both drugs until more solid phase III trial results emerge and there are question marks aplenty elsewhere. Some seven months after Pharmacia & Upjohn pulled out, the group still has to find a partner to distribute Tarabetic, the diabetic treatment which should be Scotia's first major drug to hit the market early next year.
Meantime, its long-standing businesses selling treatments based on evening primrose oil and lipid technology are struggling, as the 12 per cent dip in first-half turnover shows. Losses deepened by 31 per cent to pounds 7.03m in the six months to June. At the current rate of burn, Scotia's net cash of pounds 39.3m will be used up in about 18 months.
Even after yesterday's 42p fall to 691.5p, the shares, which capitalise Scotia at pounds 532m, look high enough for now.
Emergency call 'started off dumb, but got pretty serious'
Britain First criticised for using actress's memory to draw attention to their 'hate-filled home page'
Thought you'd seen it all after the Jeremy Paxman interview?
Greatest mystery about the hit BBC1 show is how it continues to be made at all, writes Grace Dent
"History is violent," says the US Army tank commander Don "Wardaddy" Collier
Striker's four-month ban for biting an opponent expires on Friday
Argentinian scored 'rabona' wonder goal for Tottenham in Europa League – see it here
- 1 This 'woman calls police to order pizza' story isn't going where you're expecting
- 2 Watch what happened when food critics were unknowingly served McDonald's
- 3 Jimmy Carr's controversial Oscar Pistorius joke goes a bit too far at the Q Awards
- 4 Ottawa shootings: Bruce MacKinnon's cartoon is the perfect tribute to soldier Nathan Cirillo
- 5 Of course, teenage girls need role models – but not like beauty vlogger Zoella
Isis releases first video showing the stoning of woman accused of committing adultery as her father shouts 'don't call me Dad'
This 'woman calls police to order pizza' story isn't going where you're expecting
FCKH8: YouTube reinstates provocative anti-sexism video showing young girls swearing
Diwali: What is the festival of lights – and how is it celebrated around the world?
Jimmy Carr's controversial Oscar Pistorius joke goes a bit too far at the Q Awards
Of course, teenage girls need role models – but not like beauty vlogger Zoella
Cameron is warned 'no possibility' of UK reducing immigration and that bid to bring in quota on migrant workers would be illegal
Support for EU membership 'at highest level since 1991' with most Brits wanting to stay 'in'
Thousands with degenerative conditions classified as 'fit to work in future' – despite no possibility of improvement
Residents should throw a street party and mix with immigrant neighbours, councils told
Attacks on 'Ukip Calypso' show how skewed people’s priorities are
iJobs Money & Business
£24000 - £28000 per annum + bonus & benefits: Ashdown Group: IT Business Syste...
£50000 - £90000 per annum + benefits: Ampersand Consulting LLP: Markit EDM (CA...
£100 - 125k: Guru Careers: A CTO / Chief Technology Officer is needed to join ...
Competitive (DOE): Guru Careers: A COO / Chief Operating Officer is needed to ...